MedTrace Logo

Behavioral Activation + Cognitive Processing Therapy for PTSD and Comorbid MDD

NCT02874131 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-11-15

No results posted yet for this study

Summary

This study is a randomized controlled trial comparing an integrated treatment, Behavioral Activation + Cognitive Processing Therapy (BA + CPT), to CPT alone among active-duty service members with posttraumatic stress disorder (PTSD) and comorbid major depressive disorder (MDD). Participants will complete assessor-administered and self-report measures at pre- and post-treatment assessments, as well as a 3-month follow-up. Additionally, participants will complete self-report measures of PTSD and MDD symptoms at each therapy session.

Conditions

Interventions

BEHAVIORAL

Behavioral Activation

Behavioral activation

BEHAVIORAL

Cognitive Processing Therapy

Cognitive processing therapy

Sponsors & Collaborators

  • Naval Health Research Center

    collaborator FED

  • United States Naval Medical Center, San Diego

    lead FED

Principal Investigators

  • William M. Hunt, Ph.D. · United States Naval Medical Center, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-20
Primary Completion
2022-03-18
Completion
2022-03-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02874131 on ClinicalTrials.gov